Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
Authors:
Open Access
- 13 October 2022
- journal article
- letter
- Published by Springer Nature in Cell Discovery
- Vol. 8 (1) , 1-3
Abstract
No abstract availableKeywords
All Related Versions
This publication has 5 references indexed in Scilit:
- Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75bioRxiv, 2022
- Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5New England Journal of Medicine, 2022
- Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 VaccinesNew England Journal of Medicine, 2022
- Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5Nature, 2022
- Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineagesCell Host & Microbe, 2022